U.S. CMF Market to Experience Steady Growth, Report Claims

US Market for Craniomaxillofacial Devices to Exceed $1.2 Billion by 2020, says GlobalData

The U.S. market for craniomaxillofacial (CMF) devices was valued at $803.5 million in 2013 and will expand at a compound annual growth rate (CAGR) of 6.4 percent to reach just under $1.24 billion by 2020, according to London, U.K.-based research and consulting firm GlobalData.

According to one of the company’s latest reports, while most orthopedic markets were hit hard by the economic downturn in the past five years, the CMF space, which covers plate and screw fixation, distraction, cranial flap fixation, temporomandibular joint (TMJ) replacement, CMF bone graft substitutes, and thoracic fixation, will witness stable growth over the forecast period.

Linda Tian, MSc, GlobalData’s analyst covering medical devices, said: “Lingering economic concerns in the US have significantly impacted hospital budgets and resulted in downward pricing pressures, limiting market growth.

“U.S. healthcare providers and regulatory authorities are implementing cost-containment policies, incorporating so-called ‘appropriateness criteria’ into treatment guidelines. This leads to the delayed adoption of premium CMF devices, such as patient-specific implants.”

Despite this, GlobalData expects that heightened patient awareness, coupled with the supply side’s efforts in product line extensions and medical training, will help to accelerate U.S. surgeons’ adoption of advanced technologies, such as virtual surgical planning for reconstructive and orthognathic (surgery to correct conditions of the jaw and face) surgeries.

“The U.S. is a particularly lucrative market due to increasingly higher CMF procedure volumes, boosted by the non-elective nature of a significant portion of CMF surgeries,” Tian said. “Besides increased patient awareness, key drivers of this include a trend towards early surgical intervention in younger patients, expanded insurance coverage under the Affordable Care Act, and domestic manufacturers’ continuous implant innovations.”

Of the various available technologies, CMF plate and screw fixation devices will remain the largest contributors to the US market, with their value forecast to rise from $587 million in 2013 to a little more than $895 million by 2020, representing a CAGR of 6.2 percent, according to GlobalData.